# Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents

> **NCT02964377** · PHASE1,PHASE2 · COMPLETED · sponsor: **Craig McDonald, MD** · enrollment: 15 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** (+)- Epicatechin

## Key facts

- **NCT ID:** NCT02964377
- **Lead sponsor:** Craig McDonald, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02964377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02964377, "Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02964377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*